Heart disease study aims to unlock genetic secrets of dilated cardiomyopathy

NCT ID NCT03843255

Ongoing Knowledge-focused Sponsor: Imperial College London Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 2000 people with dilated cardiomyopathy (a weakened, enlarged heart) over several years to learn how genetics and heart scarring affect the disease. Participants give blood for genetic testing and have heart MRI scans. The goal is to improve diagnosis and pave the way for future personalized treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder dilated cardiomyopathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOVASCULAR DISEASES DILATED CARDIOMYOPATHY

Contacts and locations

Locations

Glenfield Hospital

Leicester, LE3 9QP, United Kingdom
Leeds Teaching Hospitals NHS Trust

Leeds, LS1 3EX, United Kingdom
Liverpool Heart and Chest Hospital NHS Foundation Trust

Liverpool, L14 3PE, United Kingdom
Oxford University Hospitals NHS Foundation Trust

Oxford, United Kingdom
Royal Brompton & Harefield NHS Foundation Trust

London, SW3 6NP, United Kingdom
Southampton General Hospital

Southampton, SO16 6YD, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.